FDA Drug Recall Classes: What Class I, II, and III Mean

The three recall classes at a glance

The FDA groups every drug recall into one of three classes based on how dangerous the product is to consumers. Class I is the most serious. Class III is the least.

Class	Risk Level	Example
Class I	Could cause death or serious injury	Contaminated injectable drugs
Class II	May cause temporary or reversible health problems	Wrong dosage on label
Class III	Unlikely to cause health harm	Minor labeling violation

What triggers a Class I recall?

A Class I recall means the product has a reasonable probability of causing serious adverse health consequences or death. These are rare but get the most media attention.

Common triggers include:

Microbial contamination in sterile products
Incorrect active ingredient
Undeclared allergens in compounded medications
Packaging mix-ups between high-risk drugs

The FDA issued 23 Class I drug recalls between January and July 2026, according to the openFDA enforcement reports database.

Class II: the most common category

About 70-75% of all drug recalls fall into Class II. These cover situations where a product might cause temporary health problems, or where the probability of serious harm is remote.

Typical Class II triggers:

Dissolution test failures (tablet does not break down properly)
cGMP deviations during manufacturing
Stability failures (drug degrades before expiration date)
Particulate matter found in liquid formulations

Class III: labeling and cosmetic issues

Class III recalls involve products that violate FDA regulations but are unlikely to cause any health reaction. A missing lot number, a typo in the package insert, or a container that does not meet child-resistant standards.

These rarely make headlines, but they account for about 20-25% of all recalls.

How to track recalls with the openFDA API

The FDA Enforcement Reports API provides machine-readable access to all recall data. A query for Class I drug recalls looks like this:

curl "https://api.fda.gov/drug/enforcement.json?search=classification:\"Class+I\"&limit=10"

The response includes the recalling firm, product description, reason for recall, distribution pattern, and recall initiation date.

Key fields in the response:

classification - Class I, II, or III
reason_for_recall - Free text description
product_description - What the drug is
recalling_firm - Company name
recall_initiation_date - When the recall started
status - Ongoing, Completed, or Terminated

Voluntary vs. FDA-mandated recalls

Most recalls are voluntary. The manufacturer discovers the problem and initiates the recall on their own. The FDA has authority to mandate a recall under 21 USC 360h, but this is rare for drugs.

The distinction matters for data analysis: voluntary recalls may appear in the database weeks after the actual withdrawal from market, while mandated recalls tend to appear faster because the FDA is directly involved in the process.

What the data tells us about 2026 trends

Through the first seven months of 2026, the openFDA enforcement database shows 847 total drug recall events. The breakdown:

Class I: 23 (2.7%)
Class II: 612 (72.3%)
Class III: 212 (25.0%)

These numbers are roughly consistent with 2024 and 2025 patterns. The FDA has maintained a steady enforcement pace despite ongoing manufacturing capacity challenges in the generic drug space.

FAQ

How long does a typical drug recall take? Most Class II recalls resolve within 6-12 months. Class I recalls often complete faster due to urgency, typically within 3-6 months.

Does a recall mean the drug is dangerous? Not always. Class III recalls involve products with no real health risk. Even some Class II recalls cover issues that are unlikely to harm most patients.

Can I get notified about new recalls? The FDA publishes an RSS feed for enforcement reports. The openFDA API also supports date-range queries, so automated daily checks are straightforward to build.

Where does recall data come from? Manufacturers report recalls to the FDA. The FDA reviews, classifies, and publishes the data through enforcement reports and the openFDA API.